Rx-360’s initiative to form a consortium that establishes shared audit programs and adopts existing quality standards is a positive step towards ensuring ethical supply chain practices. By fostering transparency and collaboration in the pharmaceutical supply chain, the consortium helps mitigate risks associated with adulteration and fraud, contributing to public accountability and safeguarding patient safety. This initiative contrasts sharply with practices that undermine supply chain integrity in authoritarian models.

Pharma Industry Consortium Rx-360 Tackles Supply-Chain Security